Methods for reducing Intraocular Pressure using A3 Adenosine Receptor Antagonists (U.S. Patent Number 6,528,516)

Acronym: Not Available NIDDK Contact: Principal Investigator(s): Kenneth Jacobson


This invention relates to a method of decreasing intraocular pressure by administrating an A3 subtype adenosine receptor antagonist, a calmodulin antagonist or an antiestrogen such as tamoxifen.‚Äč

Click outside of the light box to close the box.